AU2001278323A1 - Modified sialic acid vaccines - Google Patents

Modified sialic acid vaccines

Info

Publication number: AU2001278323A1
Authority: AU; Australia
Prior art keywords: sialic acid; acid vaccines; modified sialic; modified; vaccines
Prior art date: 2000-07-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001278323A

Inventor

Silvia Borrelli

Harold J Jennings

Wei Zou

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

National Research Council of Canada

Original Assignee

National Research Council of Canada

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-28

Filing date

2001-07-26

Publication date

2002-02-13

2001-07-26 Application filed by National Research Council of Canada filed Critical National Research Council of Canada

2002-02-13 Publication of AU2001278323A1 publication Critical patent/AU2001278323A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
- A61K39/001171—Gangliosides, e.g. GM2, GD2 or GD3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cell Biology (AREA)
Mycology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Oncology (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AU2001278323A 2000-07-28 2001-07-26 Modified sialic acid vaccines Abandoned AU2001278323A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US22155200P	2000-07-28	2000-07-28
US60/221,552		2000-07-28
PCT/CA2001/001080 WO2002009744A2 (en)	2000-07-28	2001-07-26	Modified sialic acid vaccines

Publications (1)

Publication Number	Publication Date
AU2001278323A1 true AU2001278323A1 (en)	2002-02-13

Family

ID=22828279

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001278323A Abandoned AU2001278323A1 (en)	2000-07-28	2001-07-26	Modified sialic acid vaccines

Country Status (5)

Country	Link
US (1)	US20040009195A1 (en)
EP (1)	EP1307221A2 (en)
AU (1)	AU2001278323A1 (en)
CA (1)	CA2417574A1 (en)
WO (1)	WO2002009744A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8148335B2 (en)	2004-06-23	2012-04-03	Children's Hospital & Research Center Oakland	De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
KR20070060069A (en)	2004-06-23	2007-06-12	칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드	Polysaccharide Derivatives and Uses in Induction of Immune Responses
AU2005282449B2 (en) *	2004-09-07	2011-07-14	Velico Medical, Inc.	Apparatus for prolonging survival of platelets
AU2008272792B2 (en)	2007-07-03	2014-03-06	Children's Hospital & Research Center At Oakland	Oligosialic acid derivatives, methods of manufacture, and immunological uses
US8999954B2 (en)	2007-07-03	2015-04-07	Childern's Hospital & Research Center at Oakland	Inhibitors of polysialic acid de-N-acetylase and methods for using the same
WO2011149778A1 (en) *	2010-05-26	2011-12-01	Ancora Pharmaceuticals Inc.	Synthetic oligosaccharides for neisseria meningitis vaccine
CN114085254B (en) *	2020-08-24	2023-10-20	上海交通大学	Ganglioside GM3 derivative, and preparation method and application thereof
WO2023129737A1 (en) *	2021-12-31	2023-07-06	Aviceda Therapeutics, Inc.	Glycomimetic ligands
US12168783B2 (en) *	2023-04-02	2024-12-17	David Michaeli	Oncodialysis system and method for personalized autologous cancer vaccine and blood purification

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1337403C (en) *	1988-03-28	1995-10-24	Biomembrane Institute (The)	Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones
US5102663A (en) *	1988-10-18	1992-04-07	Sloan-Kettering Instutute For Cancer Research	Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3
US5811102A (en) *	1995-06-07	1998-09-22	National Research Council Of Canada	Modified meningococcal polysaccharide conjugate vaccines
WO2000007602A1 (en) *	1998-08-06	2000-02-17	The Johns Hopkins University School Of Medicine	Compounds for altering cell surface sialic acids and methods of use therefor
CA2279134A1 (en) *	1999-07-29	2001-01-29	Tianmin Liu	Novel strategy for carbohydrate-based therapeutic vaccines

2001
- 2001-07-26 CA CA002417574A patent/CA2417574A1/en not_active Abandoned
- 2001-07-26 AU AU2001278323A patent/AU2001278323A1/en not_active Abandoned
- 2001-07-26 WO PCT/CA2001/001080 patent/WO2002009744A2/en not_active Ceased
- 2001-07-26 EP EP01956230A patent/EP1307221A2/en not_active Withdrawn
- 2001-07-26 US US10/343,039 patent/US20040009195A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2417574A1 (en)	2002-02-07
US20040009195A1 (en)	2004-01-15
WO2002009744A2 (en)	2002-02-07
EP1307221A2 (en)	2003-05-07
WO2002009744A3 (en)	2002-10-03

Publication	Publication Date	Title
AU2002336760A1 (en)	2003-06-10	Mutable vaccines
AU2002236159A1 (en)	2002-07-16	Immunogenic complex
AU2001269529A1 (en)	2002-01-30	Medicine comprising dicyanopyridine derivative
AU2001264147A1 (en)	2002-01-02	Drive system
AU2001265111A1 (en)	2001-12-11	Benzenedicarboxylic acid derivatives
AU2002254558A1 (en)	2002-11-11	Novel vaccine
AU2001278755A1 (en)	2002-03-04	Injections
AU6600300A (en)	2001-03-13	Pneumococcal vaccines
AU2001280167A1 (en)	2002-03-13	Novel propenohydroxamic acid derivatives
AU2001253568A1 (en)	2001-10-30	Lipopolysaccharide-conjugate vaccine for sepsis treatment
AU2002214978A1 (en)	2002-06-13	Beta-Thio-amino acids
AU5977700A (en)	2001-01-31	Vaccines
AU2001278323A1 (en)	2002-02-13	Modified sialic acid vaccines
AU1738201A (en)	2001-05-08	Adjuvants for nucleic acid vaccines
AU1600401A (en)	2001-06-06	Malaria vaccine
AU6158700A (en)	2001-01-30	Vaccine
AU2002249823A1 (en)	2002-07-25	Acne vaccine
AU2001247453A1 (en)	2001-09-24	Genetically stable cholera vaccines
AU2001267541A1 (en)	2001-12-11	Vaccine composition
AU2002327959A1 (en)	2003-04-22	Adjuvants for nucleic acid vaccines
AU2001284630A1 (en)	2002-03-26	Drive system
AU5811600A (en)	2000-12-28	Vaccine
AU2001223394A1 (en)	2001-07-31	Framework system
AU2002357506A1 (en)	2003-07-15	Acid-containing preparations
AU1101701A (en)	2001-05-08	Vaccine compositions